SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-24-004900
Filing Date
2024-01-19
Accepted
2024-01-19 16:40:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea191470-424b5_altamira.htm 424B5 488579
2 GRAPHIC image_001.jpg GRAPHIC 5241
  Complete submission text file 0001213900-24-004900.txt   497304
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-261127 | Film No.: 24546144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)